Inquirer on MSN1d
PH harm reduction advocates welcome US FDA marketing authorizations for ZYN
Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...
manilastandard2d
US FDA marketing authorizations for Zyn encourage Filipino harm reduction advocates
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
BGR15d
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
Today15d
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...
19 Action News16d
The FDA says it has approved a new non-addictive pain medication
The drug is suzetrigine under the brand name Journavx. It is now FDA-approved to treat moderate to severe acute pain, which is usually caused by injury, trauma or surgery. Pain is registered in ...
News Medical16d
New FDA initiatives focus on medication safety for pregnant and nursing women
When the U.S. Food and Drug Administration approves a prescription medication ... prescription medications has been updated with the FDA's revised pregnancy and breastfeeding labeling format ...
KTTC16d
The FDA says it has approved a new non-addictive pain medication
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...
Big News Network.com16d
ADB approves 500 mln USD loan to boost Philippines' labor market reforms
MANILA, Jan. 30 (Xinhua) -- The Asian Development Bank (ADB) on Thursday said it has approved a 500-million-U.S. dollar policy-based loan to support job creation and workforce development in the ...
C&EN24d
50 new drugs received FDA approval in 2024
The FDA also gave its nod to Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), the first new class of antischizophrenia drug to be approved in decades. Roughly one-third of last ...
Newsweek24d
FDA Approves Nasal Spray for Depression
However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...
btimesonline24d
FDA Approves Johnson & Johnson's Spravato as Standalone Treatment for Depression
Of these, about one-third struggle with symptoms that traditional treatments fail to address. Spravato's new designation expands its initial FDA approval in 2019, which allowed its use only alongside ...
CNN25d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...